Zhejiang, China

Desong Shi

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Novartis Ag, Zhejiang Jiuzhou Pharmaceutical Co., Ltd.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Desong Shi. Retrieved from https://idiyas.com/inventor/desong-shi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Desong Shi: Innovator in the Pharmaceutical Industry

Introduction

Desong Shi is a notable inventor based in Taizhou, China. He has made significant contributions to the pharmaceutical industry through his work with various companies. Although he currently holds no patents, his experience and collaborations have shaped his career.

Latest Patents

As of now, Desong Shi has not registered any patents. This may reflect his focus on collaborative projects and contributions within the companies he has worked for.

Career Highlights

Desong Shi has worked with prominent organizations such as Zhejiang Jiuzhou Pharmaceutical Co., Ltd. and Novartis AG. His roles in these companies have allowed him to gain valuable insights and experience in the pharmaceutical sector.

Collaborations

Desong has collaborated with various professionals, including his coworker Guoliang Zhu. These partnerships have likely enhanced his knowledge and skills in the field.

Conclusion

Desong Shi is an influential figure in the pharmaceutical industry, with a career marked by significant experience and collaboration. His journey reflects the importance of teamwork and innovation in driving advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…